Whispering Oaks International Inc. Announces Change in Business and New Name.Business Editors LAS VEGAS--(BUSINESS WIRE)--April 20, 2001 Whispering Oaks International Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BOCX) is now doing business as BioCurex Inc. to reflect its new operations in biotechnology and has filed the appropriate notification with the state of Texas. The new name will be submitted for ratification at a forthcoming meeting of the shareholders along with a proposed change in domicile domicile (dŏm`əsīl'), one's legal residence. This may or may not be the place where one actually resides at any one time. The domicile is the permanent home to which one is presumed to have the intention of returning whenever the purpose from Texas to Nevada. The name change to BioCurex reflects the purchase of all the issued and outstanding shares of Lagostar Trading S.A., a company in the business of biotechnology and holding specific intellectual technology and patents for cancer diagnostics and therapeutics. BioCurex has also acquired the biotechnology assets and undertakings of Curex Technologies Inc., a Canadian biotechnology company, in exchange for certain promissory notes promissory note, unconditional written promise to pay a certain sum of money at a definite time to bearer or to a specified person on his order. Promissory notes are generally used as evidence of debt. . BioCurex is a biotechnology company that has developed patented/proprietary technology in the areas of cancer diagnosis, tumor tumor: see neoplasm. imaging and therapeutics. The technology identifies a universal cancer biomarker or receptor known as RECAF, thereby allowing detection of malignant cancers from blood tests or tissue biopsies. The cancer diagnostics market is presently estimated at $4 billion. The technology can also be used to image the location of the cancer and improve the present detection systems. Accurate and timely diagnosis is the vital first step in managing cancer and it is projected that BioCurex can obtain a leadership position in the screening, diagnosis and imaging of cancer. Initial results indicate that this technology can detect more than 90% of all cancers in blood and tissue samples. Forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. contained in this news release are made under the Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Provision of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any such statements are subject to risks and uncertainties that could cause actual results of events to differ materially from those anticipated in such forward-looking statements. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion